Closing the Gap in Genomic Testing & Targeted Treatments belongs in serious BCBA study because it shapes whether behavior-analytic decisions stay useful once they leave a clean training example and enter clinic sessions and day-to-day service delivery. In Closing the Gap in Genomic Testing & Targeted Treatments, for this course, the practical stakes show up in stronger conceptual consistency and better translational decision making, not in abstract discussion alone.
Provider: BehaviorLive — via AVBCC
Take This Course →Including ethics, supervision, and topics like this one. New live CEU every Wednesday.
Join Free →Biomarker-targeted therapies have transformed cancer treatment, making it increasingly personalized based on a tumor's genetic makeup. To access these therapies, patients must undergo biomarker testing, guided by clinical guidelines. Clinicians face significant challenges in ordering the right tests and applying results to treatment decisions. They must keep up with rapid scientific advancements, navigate payer requirements, weigh the benefits of testing against potential delays or risks, and interpret growing volumes of patient data. Despite best efforts, many eligible patients go untested, missing critical opportunities for more effective treatment. In this panel, we will: Identify key barriers to biomarker testing and targeted therapy access, including, knowledge: Keeping pace with scientific innovation and evolving guidelines, Operations: Overcoming workflow inefficiencies and knowledge gaps, Financial: Addressing costs and payer-related hurdles, Explore initiatives aimed at closing these gaps, such as, Developing quality metrics to improve testing rates, Leveraging technology at the point of care to drive guideline-concordant testing and treatment, Enhancing the actionability of genomic data to incentivize testing, Streamlining reimbursement processes for greater accessibility Discuss the real-world impact of these initiatives on physician behavior, barriers that remain, and opportunities to drive broader adoption.
| Certification Body | Credits | Type |
|---|---|---|
| BACB | 1 | General |
Dr. Stephen Speicher is a pediatric hematologist and oncologist, healthcare IT and innovation expert andhealthcare systems engineer. He is focused on improving quality and safety in healthcare deliverythrough technology. Dr. Speicher currently serves as a Senior Medical Director and head of HealthcareQuality and Safety at Flatiron Health working to create innovative products to drive value for oncologistsand oncology patients. Dr. Speicher completed his medical degree at UCLA, followed by a residency inpediatrics at the Children’s Hospital of Los Angeles and a fellowship in hematology and oncology back atUCLA. He then went on to receive a master’s degree in healthcare systems engineering and an advancedfellowship in Biodesign Innovation. Part of Dr. Speicher’s role at Flatiron is better understanding how technology impacts health equity. Heworks closely with the developers on his team along with customers throughout the US to ensuretechnology being developed is not increasing disparities in care but instead contributing to efforts tocreate more equity across populations. Dr. Speicher believes that technology, if created with intention,can be a tremendous contributor to the pursuit of healthcare that is safe, high quality and equitable.
Dig into the research behind this topic — plain-English summaries written for BCBAs.
280 research articles with practitioner takeaways
279 research articles with practitioner takeaways
256 research articles with practitioner takeaways
You earn CEUs from a dozen different places. Upload any certificate — from here, your employer, conferences, wherever — and always know exactly where you stand. Learning, Ethics, Supervision, all handled.
No credit card required. Cancel anytime.
All behavior-analytic intervention is individualized. The information on this page is for educational purposes and does not constitute clinical advice. Treatment decisions should be informed by the best available published research, individualized assessment, and obtained with the informed consent of the client or their legal guardian. Behavior analysts are responsible for practicing within the boundaries of their competence and adhering to the BACB Ethics Code for Behavior Analysts.